Mycronic AB (publ)
MICLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $7 | $6 | $5 | $5 |
| % Growth | 23.7% | 11.5% | 10.4% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $2 |
| Gross Profit | $4 | $3 | $2 | $2 |
| % Margin | 52.7% | 50.1% | 44.7% | 49.3% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $1 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $1 | $0 | $0 |
| Other Operating Expenses | $1 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $1 | $1 |
| Operating Income | $2 | $1 | $1 | $1 |
| % Margin | 28.5% | 21.2% | 17.5% | 21.5% |
| Other Income/Exp. Net | $0 | $0 | -$0 | $0 |
| Pre-Tax Income | $2 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $2 | $1 | $1 | $1 |
| % Margin | 23.8% | 17.5% | 14.5% | 17.9% |
| EPS | 8.63 | 5.11 | 3.8 | 4.24 |
| % Growth | 68.9% | 34.5% | -10.4% | – |
| EPS Diluted | 8.62 | 5.11 | 3.8 | 4.24 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $1 | $1 | $1 |
| % Margin | 33.5% | 24.3% | 21.7% | 24.9% |